The Cancer Letter

Inside information on cancer research and drug development

In Brief

Sameer Keole voted president-elect of ASTRO; science and health policy officers elected to board

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

Three new officers were elected to ASTRO’s board of directors, including Sameer Keole, as president-elect; Wendy Woodward, as Science Council vice chair; and Vivek S. Kavadi, as Health Policy Council vice chair. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

In Brief

House Energy and Commerce Committee Democratic leaders urge FDA to advance clinical trial diversity efforts

Energy and Commerce Committee Health Subcommittee Ranking Member Rep. Anna G. Eshoo (D-CA), Ranking Member Rep. Frank Pallone, Jr. (D-NJ), and Oversight and Investigations Subcommittee Ranking Member Rep. Kathy Castor (D-FL) wrote to FDA Commissioner Robert M. Califf to urge the agency to move forward with guidance to improve the diversity of populations represented in clinical trials.
Table of Contents

Login

Site license subscribers:
Log in with your IP | Register a sponsored account